Maria L. G. Quiloan, John Vu and John Carvalho. Enterococcus faecalis can be distinguished from Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation characteristics on mannitol salt agar. Front. Biol. 7(2): 167-177, 2012....
and at least 18 of the 26 phase-I candidates were targeted to treat Gram-negative bacteria infections. Despite the promising early-stage antibacterial pipeline, it is essential to maintain funding for antibacterial R&D and to ensure that plans to address late-stage pipeline issues succeed....
Entero- coccus faecalis can be distinguished from Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation characteristics on... MLG Quiloan,VU John,J Carvalho - 《生物学前沿:英文版》 被引量: 0发表: 2012年 Enterococcus faecalis can be distinguished from Enterococc...
and at least 18 of the 26 phase-I candidates were targeted to treat Gram-negative bacteria infections. Despite the promising early-stage antibacterial pipeline, it is essential to maintain funding for antibacterial R&D and to ensure that plans to address late-stage pipeline issues succeed....
In addition to its bacterial inhabitants, the gut contains an equally fascinating viral community that exerts a profound effect on the microbiota and, in turn, on the host. As the natural predators of bacteria, phages were used to treat bacterial infections before the advent of antibiotics, after...
Ursolic Acid Loaded Chitosan Coated Silver Nanoparticles Exhibits Robust Antibacterial Activity Against Drug Resistant Nosocomial Pathogens: Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, and Klebsiella peumoniae Umesh Chand Pramod Kumar Kushawaha BioNanoScience (2024) Natural products against...
faecalis in this small study. Gentamicin combined with either cefazolin or ampicillin had somewhat better bactericidal activity and should be considered as an alternative therapy. Novel therapy may be necessary to treat endophthalmitis because of vancomycin-resistant Enterococcus, depending on the ...
Antibiotic fosfomycin known for the treatment of multi-drug resistant bacterial infection (Wagenlehner et al., 2011) is a potent bactericidal against E.coli, Staphylococcus aureus, Streptococcus pneumonia, Enterococcus faecalis, and Enterococcus faecium, but some bacteria show decreased susceptibility agains...
(Qurient Co/Infectex) supplemental New Drug Application (NDA) for Avycaz, adding new clinical data to the current label from two of the phase-III trials that evaluated Avycaz, in combination with metronidazole, for the treat- ment of cIAI, including patients with infections due to ceftazidime-...
Multidrug-resistant bacteria, especially those that defy even last-resort antibiotics, are causing a global health crisis fuelled by antibiotic overuse and misuse as well as the lack of development of new antibiotics. Multidrug-resistant bacteria comprom